Page values for "Tizanidine"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Tizanidine |
| brand | String | Zanaflex |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Skeletal muscle relaxants|Skeletal muscle relaxant (centrally-acting)]] • [[:Category:Alpha-2 adrenergic agonists|Alpha-2 adrenergic agonist]] • [[:Category:Antispastics|Antispastic]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000019-QINU`"', '"`UNIQ--vote-0000001A-QINU`"', '"`UNIQ--vote-0000001B-QINU`"', '"`UNIQ--vote-0000001C-QINU`"' |
| starting_dose | String | 2 mg PO every 6-8 hours; titrate by 2-4 mg per dose every 1-4 days; maximum single dose 16 mg, maximum daily dose 36 mg |
| preparations | String | Tablets 2, 4 mg; capsules 2, 4, 6 mg ('''capsules and tablets are not bioequivalent''': capsules slower with food; tablets faster on empty stomach) |
| fda_max | String | 36 mg/day in three divided doses; single dose maximum 16 mg |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | 30-60 minutes |
| duration | String | 3-6 hours per dose |
| halflife | String | 2.5 hours (short, requires TID-QID dosing)'"`UNIQ--ref-0000001D-QINU`"' |
| bioavailability | String | ~40% (oral); food and formulation substantially alter the absorption profile'"`UNIQ--ref-0000001E-QINU`"' |
| pregnancy | String | Limited human data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US. Not a controlled substance, distinguishing it from carisoprodol among muscle-spasm options'"`UNIQ--ref-0000001F-QINU`"' |